These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 4677588)

  • 1. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
    Haba S; Kitagawa M
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunocompetent cells in graft rejection.
    Möller G
    Transplant Proc; 1971 Mar; 3(1):15-20. PubMed ID: 4106300
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of activated macrophages in nonspecific resistance to neoplasia.
    Hibbs JB
    J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals.
    Hellström I; Hellström KE; Kall MA; Nelson K; Pollack S
    Transplant Proc; 1976 Jun; 8(2):255-64. PubMed ID: 936286
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunodepressive action of the tumor].
    Belokhvostov AS
    Vopr Onkol; 1978; 24(3):99-106. PubMed ID: 347712
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 8. Workshop in human tumor immunology.
    Oettgen HF; Bean MA; Klein G
    Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic spread and "escape" from the immune defenses of the host.
    Alexander P
    Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic aspects of cancer.
    Sophocles AM; Nadler SH
    Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular and humoral immune interactions during neoplastic development.
    Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
    Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of immunologic enhancement.
    Amos DB; Cohen I; Klein WJ
    Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular mechanisms of transplantation and tumor immunity].
    Brunner KT
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1144-7. PubMed ID: 4403396
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxic immune cells with specificity for defined soluble antigens. V. Interaction of antibody with the cytotoxic effector cells in immune or non-immune mouse spleen cells.
    Schirrmacher V; Rubin B; Pross H
    J Immunol; 1974 Jun; 112(6):2219-26. PubMed ID: 4856907
    [No Abstract]   [Full Text] [Related]  

  • 15. Blocking antibodies and enhancement.
    Heppner GH
    Ser Haematol; 1972; 5(4):41-66. PubMed ID: 4364363
    [No Abstract]   [Full Text] [Related]  

  • 16. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():301-5. PubMed ID: 4607384
    [No Abstract]   [Full Text] [Related]  

  • 17. Nutrition and tumor immunity: divergent effects of antitumor antibody.
    Bull DM
    Cancer Res; 1975 Nov; 35(11 Pt. 2):3317-9. PubMed ID: 1104143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immune mechanisms of tumor cell destruction.
    Perlmann P; O'Toole C; Unsgaard B
    Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular immunity and blocking antibodies to tumors.
    Hellström I; Hellström KE
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunotherapy of cancer.
    Parker CW
    Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.